Australia Stock Exchange release from ATOMO DIAGNOSTIC : Atomo receives approval for its COVID-19 antigen test in NZ
26/01/2022 22:48
Australia Stock Exchange release from ATOMO DIAGNOSTIC AT1.AX : Atomo receives approval for its COVID-19 antigen test in NZ
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Signs Agreement With Innovation Scientific
Brief: Atomo Diagnostics Ltd Appoints Cheri Walker As Interim Ceo
Brief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt